Skip to main content
OpenTrials

Clinical trial condition

PSMA PET-Positive Castration-Resistant Prostate Cancer

Explore clinical trials studying PSMA PET-Positive Castration-Resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

PSMA PET-Positive Castration-Resistant Prostate Cancer trial results

Recruiting

Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)

NCT06549465

Conditions
PSMA PET-Positive Castration-Resistant Prostate Cancer
Locations
  • University of California San Diego San Diego, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • X Cancer Omaha / Urology Cancer Center Omaha, Nebraska, United States
View Trial Details

Related conditions